[{"id":"8e1bb0a8-fb40-48f3-8d78-11c776c28c97","acronym":"","url":"https://clinicaltrials.gov/study/NCT00898846","created_at":"2021-01-18T03:27:14.501Z","updated_at":"2024-07-02T16:37:28.825Z","phase":"","brief_title":"Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery","source_id_and_acronym":"NCT00898846","lead_sponsor":"Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan","biomarkers":" MSI • TYMS","pipe":"","alterations":" ","tags":["MSI • TYMS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tegafur/uracil"],"overall_status":"Completed","enrollment":" Enrollment 1111","initiation":"Initiation: 10/01/2006","start_date":" 10/01/2006","primary_txt":" Primary completion: 10/01/2015","primary_completion_date":" 10/01/2015","study_txt":" Completion: 09/01/2016","study_completion_date":" 09/01/2016","last_update_posted":"2016-09-28"},{"id":"0b480c67-944a-48e3-8371-b448d4719898","acronym":"","url":"https://clinicaltrials.gov/study/NCT02887365","created_at":"2021-01-18T14:10:15.959Z","updated_at":"2024-07-02T16:37:29.306Z","phase":"Phase 4","brief_title":"A Phase II Study of Tegafur-Uracil as Maintenance Chemotherapy in Patients With Stage II of Colon Cancer","source_id_and_acronym":"NCT02887365","lead_sponsor":"National Taiwan University Hospital","biomarkers":" MSI","pipe":"","alterations":" ","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e tegafur/uracil"],"overall_status":"Unknown status","enrollment":" Enrollment 300","initiation":"Initiation: 09/01/2014","start_date":" 09/01/2014","primary_txt":" Primary completion: 08/01/2017","primary_completion_date":" 08/01/2017","study_txt":" Completion: 08/01/2017","study_completion_date":" 08/01/2017","last_update_posted":"2016-09-07"}]